Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Other Non Operating Income (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Other Non Operating Income for 2 consecutive years, with $60000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 300.0% to $60000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $523000.0 through Dec 2025, down 79.84% year-over-year, with the annual reading at $523000.0 for FY2025, 79.84% down from the prior year.
  • Other Non Operating Income hit $60000.0 in Q4 2025 for Connect Biopharma Holdings, up from -$7000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.7 million in Q1 2024 to a low of -$108000.0 in Q3 2024.